secwatch.observer — SEC 8-K summary
======================================

Issuer:     BECTON DICKINSON & CO (BDX)
CIK:        0000010795
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001628280-25-049835
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BD Q4 revenue $5.9B (+8.3%); FY25 adjusted EPS $14.40 (+9.6%); FY26 guidance
----------------------------------------------------------------------------

- Q4 revenue $5,890M, up 8.3% as reported, 3.9% organic; GAAP EPS $1.72, adjusted EPS $3.96.
- FY25 revenue $21.8B (+8.2% as reported); GAAP EPS $5.82 (-0.7%), adjusted EPS $14.40 (+9.6%).
- FY25 adjusted operating margin up 80 bps to 25.0%; adjusted gross margin up 140 bps.
- Returned $2.2B to shareholders in FY25 via dividends and share repurchases.
- Biosciences/Diagnostic Solutions combination with Waters Corp on track to close near end of Q1 CY2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/0001628280-25-049835-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/10795/000162828025049835/bdx-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-049835

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer